Comparative, Open Multicenter Trial Assessing the Effect on Albumin Excretion Rate of 320mg Valsartan (With or Without HCTZ) vs 40mg Lisinopril (With or Without HCTZ) on Hypertensive Patients With Diabetic and Non-Diabetic Nephropathy and Albuminuria.
Phase of Trial: Phase IV
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Lisinopril; Valsartan
- Indications Hypertension
- Focus Pharmacodynamics
- Sponsors Novartis
- 07 Nov 2011 Actual end date (Jan 2007) added as reported by ClinicalTrials.gov.
- 19 Nov 2006 New trial record.